VICTORY CAPITAL MANAGEMENT INC
Position in AMRX — Amneal Pharmaceuticals, Inc.
CIK 1040188
San Antonio, TX
Position in AMRX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$5,742,336
+$5,514,894 QoQ
Shares Held
461,974
+2459.3% QoQ
Ownership
0.145%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in AMRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026VICTORY CAPITAL MANAGEMENT INC holds $398,774,467 across 27 Drug Manufacturers - Specialty & Generic names. AMRX ranks #13 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
731,609 | $96,382,169 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,838,437 | $55,373,722 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
60,541 | $35,899,602 | |
| 4 | ZTS |
Zoetis Inc.
|
295,063 | $34,879,397 | |
| 5 | VTRS |
Viatris Inc
|
2,394,145 | $32,344,898 | |
| 6 | SUPN |
Supernus Pharmaceuticals, Inc.
|
502,406 | $25,969,366 | |
| 7 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
506,521 | $24,388,985 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
|
625,304 | $20,678,803 |
All Filings in AMRX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,742,336 | 461,974 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $227,442 | 18,051 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $167,167 | 16,700 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $138,492 | 17,119 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $3,023,747 | 360,829 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $1,672,149 | 211,130 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $825,468 | 99,215 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $396,970 | 62,515 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $927,682 | 153,083 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $1,794,886 | 295,698 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $1,304,959 | 309,232 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $957,360 | 308,826 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $429,622 | 309,081 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $477,044 | 239,721 | Shares | Sole | 2023-04-25 | |
| 2022-09-30 | $394,433 | 195,264 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $2,624,097 | 825,188 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $5,047,163 | 1,210,351 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $5,650,528 | 1,179,651 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $5,391,440 | 1,009,633 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $9,838,028 | 1,921,490 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $12,030,965 | 1,787,662 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $782,562 | 171,239 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $378,831 | 97,637 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $222,872 | 46,822 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $167,753 | 48,205 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||